The soaring demand for antidiabetic and weight-loss drugs has lured in many biotech and big Pharma companies. Onto this ...

The biotech has named Jamie Coleman its chief commercial officer, per a Monday announcement, putting her in charge of the ...

Obesity programs: <li /> Phase 2 BMT-801 clinical study with MC4R agonist bremelanotide plus GLP-1/GIP dual agonist tirzepatide ...

This article explores methods to enhance efficiency in the drug discovery and development pipeline, focusing on optimizing ...

FGF21 is a mediator of the fasting response that increases glucose uptake, improves insulin sensitivity and reduces serum glucagon and ... FGFs and small-molecule FGF receptor kinase inhibitors ...

For some patients, injectables, such as insulin or a glucagon-like peptide-1 (GLP-1 ... Mounjaro is a single-molecule treatment that can be self-injected subcutaneously into the abdomen, thigh ...

The IRA measure is a good first step, but some are looking even further ahead to GLP-1 price drops to increase access.

Interleukin-1 (IL-1) is a key molecule involved in inflammation and plays an important role in both healthy and diseased states. With support from the U.S. Department of Health and Human Services ...

Pre-Market: 8:46:59 a.m. EST ...